Cite
HARVARD Citation
Mora, J. et al. (2020). Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic lateral sclerosis and frontotemporal degeneration. 21 (1), pp. 5-14. [Online].